Clinirx Tangent Research India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 12 Year, 29 Days
- Last Filing with ROC 31 Mar 2018
- Revenue Growth -30.58%
- Profit Growth -28.32%
- Ebitda -41.28%
- Net Worth 23.77%
- Total Assets -21.87%
About Clinirx Tangent Research India
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110WB2013PTC224480
- Company No.
224480
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2013
- Date of AGM
25 May 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
What products or services does Clinirx Tangent Research India Private Limited offer?
Clinirx Tangent Research India Private Limited offers a wide range of products and services, including Company Law & Labour Law Consultants, Statutory Compliance Services, Project Management.
Who are the key members and board of directors at Clinirx Tangent Research India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratan Jain  | Director | 24-Jan-2013 | Current |
| Surendra Malhotra | Director | 10-Feb-2014 | Current |
Financial Performance of Clinirx Tangent Research India.
Clinirx Tangent Research India Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 30.58% decrease. The company also saw a substantial fall in profitability, with a 28.32% decrease in profit. The company's net worth Soared by an impressive increase of 23.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinirx Tangent Research India?
In 2018, Clinirx Tangent Research India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Udaipur Cement Works LimitedSurendra Malhotra is a mutual person
Jk Insurance Brokers LimitedSurendra Malhotra is a mutual person
Global Strategic Technologies LimitedSurendra Malhotra is a mutual person
Sidhivinayak Trading And Investment LimitedSurendra Malhotra is a mutual person
- Param Shubham Vanijya Limited
Surendra Malhotra is a mutual person
- Sago Trading Limited
Surendra Malhotra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clinirx Tangent Research India?
Unlock and access historical data on people associated with Clinirx Tangent Research India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinirx Tangent Research India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinirx Tangent Research India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
